Catalyst Wire Dossier Catalyst Wire Dossier

SHR3824

· Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for SHR3824, covering 2015-02-03 to 2020-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 3]

See pricing